Cash Flow Statement

Asset Writedowns and Impairment Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Cash Change in Intangibles Change in Inventory Change in Receivables Depreciation & Amortization (CF)Exchange Rate Effect Free Cash Flow Net Cash Flow Net Income Other Working Capital Changes Share-based Compensation

Daily Values

Growth Metrics

Others

Ratios

Mainz Biomed (MYNZ) Amortization (2022 - 2023)

Historic Amortization for Mainz Biomed (MYNZ) over the last 2 years, with Q2 2023 value amounting to $60.0.